An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease.
This article was originally published on MedicalXpress.com
NU-9 halts Alzheimer’s disease in animal model before symptoms begin
You may also be interested in:
The Latest
Restoring Kitchen Efficiency with Oven Repair in Barrie
Preparing home-cooked meals is a great way to bring family together and maintain a healthy lifestyle. However, when your oven or range stops working properly, your entire cooking routine can come to a grinding halt. […]
Food
Transform Your Kitchen: Mastering Allergy-Safe Cooking Through Ingenious Ingredient Swaps
By Daniel Zane Bryant, author of “Living with Food Allergies: A Complete Lifestyle Guide” (available on Amazon at https://www.amazon.com/dp/B0G2BcGB2K) Navigating food allergies might initially feel overwhelming, yet it presents an exciting opportunity to reimagine familiar […]
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Read More:
-
Researchers from the Wits Vaccines and Infectious Diseases Analytics (Wits VIDA) Research Unit at the University of the Witwatersrand (Wits) have played a leading role [...]
-
Sugar restriction during the first 1,000 days after conception may significantly reduce a person’s risk of developing Alzheimer’s by up to 46%. Those are the [...]
-
A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD) and may also slow heart [...]
